Shlomit Reich-Zeliger

Title: Shlomit Reich-Zeliger: Innovator in Immunotherapy

Introduction

Shlomit Reich-Zeliger is a prominent inventor based in Rehovot, Israel. She has made significant contributions to the field of immunotherapy, particularly through her innovative patents. With a total of 2 patents, her work focuses on advancing medical treatments that harness the power of the immune system.

Latest Patents

Reich-Zeliger's latest patents include groundbreaking research on genetically modified veto cells and their application in immunotherapy. One patent details an isolated cytotoxic T-lymphocyte (CTL) that serves as a tolerance-inducing cell, which is substantially depleted of alloreactivity. This CTL does not comprise a central memory T-lymphocyte (Tcm) phenotype and is transduced to express a cell surface receptor with a T cell receptor signaling module. The patent also outlines methods for generating and utilizing these cells. Another patent presents a method of transplantation that involves administering a therapeutically effective amount of tolerance-inducing anti-third party CTLs to a subject in need. This method ensures that the CTLs are generated by directing T-lymphocytes of a donor against third-party antigens while being substantially depleted of alloreactive T-lymphocytes.

Career Highlights

Shlomit Reich-Zeliger is associated with Yeda Research and Development Co. Ltd., where she continues to push the boundaries of immunotherapy research. Her work has the potential to revolutionize transplantation methods and disease treatment, making significant strides in the medical field.

Collaborations

Reich-Zeliger has collaborated with notable colleagues, including Yair Reisner and Esther Bachar-Lustig, who have contributed to her research endeavors. Their combined expertise enhances the impact of her innovative work in immunotherapy.

Conclusion

Shlomit Reich-Zeliger is a key figure in the field of immunotherapy, with her patents paving the way for new treatment methodologies. Her contributions are vital for advancing medical science and improving patient outcomes.